SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-032528
Filing Date
2021-02-08
Accepted
2021-02-08 17:24:51
Documents
3
Group Members
BIOTECH OPPORTUNITY GP, LLCECOR1 CAPITAL FUND QUALIFIED, L.P.ECOR1 CAPITAL FUND, L.P.ECOR1 CAPITAL, LLCECOR1 VENTURE OPPORTUNITY FUND, L.P.OLEG NODELMAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d110339dsc13g.htm SC 13G 139717
2 EX-1 d110339dex1.htm EX-1 9533
3 EX-2 d110339dex2.htm EX-2 50560
  Complete submission text file 0001193125-21-032528.txt   201511
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Panacea Acquisition Corp (Subject) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91681 | Film No.: 21602601
SIC: 2834 Pharmaceutical Preparations

Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
EcoR1 Panacea Holdings, LLC (Filed by) CIK: 0001816134 (see all company filings)

IRS No.: 850890200 | Fiscal Year End: 1231
Type: SC 13G